-
Loading metrics
Comparison of cardiovascular and renal outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes without prior cardiovascular or renal disease
- Jayoung Lim,
- In-Chang Hwang,
- Hong-Mi Choi,
- Yeonyee E. Yoon,
- Goo-Yeong Cho
x
- Published: October 17, 2022
- https://doi.org/10.1371/journal.pone.0269414